## EQIX: Equinix, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 2.65 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($724.75)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 2)

**1. Equinix (EQIX) Valuation Check as Earnings Upgrades and AI Infrastructure Tailwinds Lift Investor Expectations**
- Source: Simply Wall Street | 20251223T123804 | Neutral | Relevance: 100%
- Equinix (EQIX) is gaining investor attention due to earnings upgrades and its role in AI infrastructure, despite a recent share price decline. While some analysts see the company as undervalued with a consensus price target of $957.0, a different valuation check suggests significant downside risk due to its high price-to-earnings ratio compared to industry averages. The article presents a nuanced view on whether Equinix is a value opportunity or if its growth is already priced in.

**2. Equinix (EQIX) Valuation Check as Earnings Upgrades and AI Infrastructure Tailwinds Lift Investor Expectations**
- Source: Simply Wall Street | 20251223T120804 | Somewhat-Bullish | Relevance: 100%
- Equinix (EQIX) is experiencing renewed investor interest due to positive earnings revisions and an improved rate environment, closely linking its future to AI infrastructure growth despite a 19.7% year-to-date decline. Analysts show a consensus price target of $957.0, suggesting a significant upside, while Simply Wall St's valuation model presents a contrasting view with a fair value indicating the stock is undervalued at $965.56, but its P/E ratio is substantially higher than the industry average. The article explores both bullish and bearish perspectives, highlighting potential risks like heavy capital spending and customer concentration.

**3. U.S. Capital Wealth Advisors LLC Invests $1.65 Million in Equinix, Inc. $EQIX**
- Source: MarketBeat | 20251222T130222 | Somewhat-Bullish | Relevance: 100%
- U.S. Capital Wealth Advisors LLC recently invested $1.65 million in Equinix, Inc. by acquiring 2,112 shares during the third quarter. This investment contributes to the substantial institutional ownership of Equinix, which stands at nearly 94.94%. The company also reported strong quarterly earnings, exceeding EPS expectations, and declared a quarterly dividend despite a high payout ratio.

**4. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Equinix, Inc. (EQIX) and Encourages Shareholders to Learn More About the Investigation**
- Source: WREG.com | 20251222T020834 | Somewhat-Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Equinix, Inc. (NASDAQ:EQIX). The firm is encouraging shareholders who purchased Equinix securities prior to May 3, 2019, and still hold them, to contact them to assist with the investigation. The investigation focuses on whether Equinix officers and/or directors engaged in misconduct.

**5. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Equinix, Inc. (EQIX) and Encourages Shareholders to Learn More About the Investigation**
- Source: WJBF | 20251221T210755 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Equinix, Inc. and its officers/directors. The firm is encouraging shareholders who purchased Equinix securities before May 3, 2019, and still hold them, to come forward and assist in the investigation. The investigation aims to determine if claims can be made on behalf of these investors.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | BMO Capital | $900 | $900 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | BMO Capital | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.00M) |
| Sells | 9 ($0.81M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.5% (+1.2%)
- Blackrock Inc.: 11.0% (-1.1%)
- State Street Corpora: 6.4% (+0.2%)
- JPMORGAN CHASE & CO: 5.9% (+151.6%)
- FMR, LLC: 2.7% (+12.7%)

### Key Risks

1. Premium valuation (P/E 50x, PEG 2.7x) vulnerable to multiple compression.
2. Long-term trend broken: trading 5.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.65 signals overvaluation risk, limited margin of safety. Forward P/E 49.8x stretched relative to 1% growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $74.6B |
| Beta | 1.04 |
| 52W Range | $701.41 - $964.73 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.65 |
| Forward P/E | 49.8 |
| Current P/E | 50.4 |
| YoY Growth | 1.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.2% to -0.3% (-3.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Below SMA200 (0.94x), long-term trend not supportive. MACD histogram positive (4.23), confirming momentum. RSI neutral at 50. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.32% (CS: 63) | Neutral |
| RSI_14 | 50.4 | Neutral |
| MACD Histogram | 4.23 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 0.969x | Below |
| vs SMA200 | 0.941x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $760.13
- **Stop Loss:** $724.75 (4.7% risk)
- **Target:** $795.51 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 16
- **Position Value:** $12,162.08
- **Portfolio %:** 12.16%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-11 (Est: $3.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.43 | $3.89 | +13.1% |
| 2025Q2 | $3.44 | $3.79 | +10.3% |
| 2025Q1 | $2.97 | $3.59 | +20.8% |
| 2024Q4 | $2.74 | $2.97 | +8.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*